Preprocedural statin therapy reduces the risk and extent of cardiac biomarker release following percutaneous coronary intervention
Josef Veselka(Universitat Autònoma de Barcelona), Kevin A. Bybee(Mayo Clinic), Šárka Procházková(University Hospital in Motol), Radka Duchoňová(University Hospital in Motol), Ingrid Homolová(University Hospital in Motol), David Tesař(Charles University)
Cited by 28
Related Papers
Long‐term health outcome and mortality evaluation after invasive coronary treatment using drug eluting stents with or without the IVUS guidance. Randomized control trial. HOME DES IVUS
|Catheterization and Cardiovascular Interventions|2009|190
Long-term survival after alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a comparison with general population
|European Heart Journal|2014|106
A FTO variant and risk of acute coronary syndrome
|Clinica Chimica Acta|2010|65
Parathyroid Hormone and Vitamin D Levels are Independently Associated With Calcific Aortic Stenosis
|Circulation Journal|2008|64
Effect of Catheter-Based Patent Foramen Ovale Closure on the Occurrence of Arterial Bubbles in Scuba Divers
|JACC: Cardiovascular Interventions|2014|53